Novel motif:89: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{Novel_motif
|name=motif89_CGCCGTGTTTA
|novel_motifs_human_sample_pval=11376-118A8_11051;0.177423,11327-117E4_11969;0.130928,11473-119C6_11054;0.455645,11474-119C7_12067;0....") |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 15:00, 9 September 2013
name: | motif89_CGCCGTGTTTA |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0030163 | protein catabolic process | 2.917675e-12 |
GO:0006369 | termination of RNA polymerase II transcription | 5.492613e-12 |
GO:0010498 | proteasomal protein catabolic process | 2.911334e-11 |
GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 2.988052e-11 |
GO:0006353 | transcription termination, DNA-dependent | 4.443083e-11 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 6.675499e-11 |
GO:0044257 | cellular protein catabolic process | 1.201813e-10 |
GO:0007620 | copulation | 2.991707e-10 |
GO:0016070 | RNA metabolic process | 9.846117e-10 |
GO:0035461 | vitamin transmembrane transport | 1.378126e-9 |
GO:0034393 | positive regulation of smooth muscle cell apoptosis | 1.438149e-9 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 2.759793e-9 |
GO:0019941 | modification-dependent protein catabolic process | 3.497639e-9 |
GO:0010467 | gene expression | 7.780495e-9 |
GO:0043382 | positive regulation of memory T cell differentiation | 8.464510e-9 |
GO:0043632 | modification-dependent macromolecule catabolic process | 9.056663e-9 |
GO:0090085 | regulation of protein deubiquitination | 9.366586e-9 |
GO:0006231 | dTMP biosynthetic process | 1.220672e-8 |
GO:0019088 | immortalization of host cell by virus | 1.220672e-8 |
GO:0006396 | RNA processing | 1.792419e-8 |
GO:0090086 | negative regulation of protein deubiquitination | 2.457225e-8 |
GO:0044265 | cellular macromolecule catabolic process | 3.232167e-8 |
GO:0000209 | protein polyubiquitination | 3.666189e-8 |
GO:0090304 | nucleic acid metabolic process | 4.671644e-8 |
GO:0006379 | mRNA cleavage | 5.623299e-8 |
GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c | 6.260317e-8 |
GO:0001916 | positive regulation of T cell mediated cytotoxicity | 1.823313e-7 |
GO:0007618 | mating | 2.192872e-7 |
GO:0016071 | mRNA metabolic process | 2.225550e-7 |
GO:0019087 | transformation of host cell by virus | 2.580552e-7 |
GO:0035722 | interleukin-12-mediated signaling pathway | 3.174431e-7 |
GO:0009057 | macromolecule catabolic process | 3.581264e-7 |
GO:0033326 | cerebrospinal fluid secretion | 5.602447e-7 |
GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase | 5.864838e-7 |
GO:0006397 | mRNA processing | 6.368725e-7 |
GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein | 7.870449e-7 |
GO:0030433 | ER-associated protein catabolic process | 8.518091e-7 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 8.574576e-7 |
GO:0019048 | virus-host interaction | 8.830598e-7 |
GO:0007320 | insemination | 1.028559e-6 |
GO:0046078 | dUMP metabolic process | 1.098108e-6 |
GO:2000330 | positive regulation of T-helper 17 cell lineage commitment | 1.120774e-6 |
GO:2000318 | positive regulation of T-helper 17 type immune response | 1.120774e-6 |
GO:0044260 | cellular macromolecule metabolic process | 1.275557e-6 |
GO:0006325 | chromatin organization | 1.352451e-6 |
GO:0071934 | thiamine transmembrane transport | 1.410649e-6 |
GO:0034391 | regulation of smooth muscle cell apoptosis | 1.484591e-6 |
GO:0035357 | peroxisome proliferator activated receptor signaling pathway | 1.628462e-6 |
GO:0060574 | intestinal epithelial cell maturation | 1.860711e-6 |
GO:0051290 | protein heterotetramerization | 2.376018e-6 |
GO:0031639 | plasminogen activation | 2.553101e-6 |
GO:0006535 | cysteine biosynthetic process from serine | 2.658357e-6 |
GO:0019346 | transsulfuration | 2.658357e-6 |
GO:0043418 | homocysteine catabolic process | 2.658357e-6 |
GO:0019343 | cysteine biosynthetic process via cystathionine | 2.658357e-6 |
GO:0097045 | phosphatidylserine exposure on blood platelet | 3.008074e-6 |
GO:0000375 | RNA splicing, via transesterification reactions | 3.523326e-6 |
GO:0090141 | positive regulation of mitochondrial fission | 4.463922e-6 |
GO:0050689 | negative regulation of defense response to virus by host | 4.936723e-6 |
GO:0009798 | axis specification | 4.978126e-6 |
GO:0032915 | positive regulation of transforming growth factor beta2 production | 6.146701e-6 |
GO:0008380 | RNA splicing | 6.251029e-6 |
GO:0007494 | midgut development | 6.453615e-6 |
GO:0043484 | regulation of RNA splicing | 6.813002e-6 |
GO:0030970 | retrograde protein transport, ER to cytosol | 7.485501e-6 |
GO:0000077 | DNA damage checkpoint | 8.968267e-6 |
GO:0006351 | transcription, DNA-dependent | 1.072572e-5 |
GO:0032534 | regulation of microvillus assembly | 1.088895e-5 |
GO:0051443 | positive regulation of ubiquitin-protein ligase activity | 1.127327e-5 |
GO:0048319 | axial mesoderm morphogenesis | 1.140387e-5 |
GO:0031102 | neuron projection regeneration | 1.202165e-5 |
GO:0009163 | nucleoside biosynthetic process | 1.219858e-5 |
GO:0051865 | protein autoubiquitination | 1.651740e-5 |
GO:0016568 | chromatin modification | 1.883636e-5 |
GO:0010661 | positive regulation of muscle cell apoptosis | 2.008360e-5 |
GO:0016598 | protein arginylation | 2.050577e-5 |
GO:0019376 | galactolipid catabolic process | 2.229966e-5 |
GO:0065002 | intracellular protein transmembrane transport | 2.229966e-5 |
GO:0031619 | homologous chromosome orientation involved in meiotic metaphase I plate congression | 2.240387e-5 |
GO:0006684 | sphingomyelin metabolic process | 2.287663e-5 |
GO:0031570 | DNA integrity checkpoint | 2.344302e-5 |
GO:0071674 | mononuclear cell migration | 2.403061e-5 |
GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition | 2.439429e-5 |
GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation | 2.439429e-5 |
GO:0006139 | nucleobase-containing compound metabolic process | 2.613450e-5 |
GO:0006556 | S-adenosylmethionine biosynthetic process | 3.098514e-5 |
GO:0042977 | activation of JAK2 kinase activity | 3.244135e-5 |
GO:0045090 | retroviral genome replication | 3.438709e-5 |
GO:0046985 | positive regulation of hemoglobin biosynthetic process | 3.438709e-5 |
GO:0043973 | histone H3-K4 acetylation | 3.438709e-5 |
GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 3.438709e-5 |
GO:0030185 | nitric oxide transport | 3.763925e-5 |
GO:0031571 | mitotic cell cycle G1/S transition DNA damage checkpoint | 3.827180e-5 |
GO:0032774 | RNA biosynthetic process | 4.492829e-5 |
GO:0090140 | regulation of mitochondrial fission | 4.578783e-5 |
GO:0019448 | L-cysteine catabolic process | 4.627296e-5 |
GO:0009162 | deoxyribonucleoside monophosphate metabolic process | 4.784029e-5 |
GO:0006335 | DNA replication-dependent nucleosome assembly | 4.784029e-5 |
GO:0002069 | columnar/cuboidal epithelial cell maturation | 5.943350e-5 |
GO:0006406 | mRNA export from nucleus | 6.249775e-5 |
GO:0031124 | mRNA 3'-end processing | 6.529377e-5 |
GO:0010224 | response to UV-B | 7.068311e-5 |
GO:0010506 | regulation of autophagy | 7.198184e-5 |
GO:0046683 | response to organophosphorus | 7.258925e-5 |
GO:0006400 | tRNA modification | 7.814091e-5 |
GO:0042503 | tyrosine phosphorylation of Stat3 protein | 8.027722e-5 |
GO:0000387 | spliceosomal snRNP assembly | 8.149822e-5 |
GO:0010821 | regulation of mitochondrion organization | 8.257060e-5 |
GO:0034644 | cellular response to UV | 8.465138e-5 |
GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway | 8.651199e-5 |
GO:0060248 | detection of cell density by contact stimulus involved in contact inhibition | 8.651199e-5 |
GO:0072285 | mesenchymal to epithelial transition involved in metanephric renal vesicle formation | 8.651199e-5 |
GO:0006427 | histidyl-tRNA aminoacylation | 8.651199e-5 |
GO:0045358 | negative regulation of interferon-beta biosynthetic process | 8.651199e-5 |
GO:0007371 | ventral midline determination | 8.651199e-5 |
GO:0051932 | synaptic transmission, GABAergic | 8.951793e-5 |
GO:0000073 | spindle pole body separation | 8.951793e-5 |
GO:0008616 | queuosine biosynthetic process | 8.951793e-5 |
GO:0019374 | galactolipid metabolic process | 9.193575e-5 |
GO:0048102 | autophagic cell death | 9.296942e-5 |
GO:0060658 | nipple morphogenesis | 9.296942e-5 |
GO:0071779 | G1/S transition checkpoint | 9.348068e-5 |
GO:0071482 | cellular response to light stimulus | 9.823322e-5 |
GO:0051351 | positive regulation of ligase activity | 1.028060e-4 |
GO:0045626 | negative regulation of T-helper 1 cell differentiation | 1.062153e-4 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.094985e-4 |
GO:0070842 | aggresome assembly | 1.100684e-4 |
GO:0009399 | nitrogen fixation | 1.202385e-4 |
GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | 1.232023e-4 |
GO:0032530 | regulation of microvillus organization | 1.298280e-4 |
GO:0072404 | signal transduction involved in G1/S transition checkpoint | 1.318132e-4 |
GO:0042770 | signal transduction in response to DNA damage | 1.433141e-4 |
GO:0048318 | axial mesoderm development | 1.503090e-4 |
GO:0031123 | RNA 3'-end processing | 1.516388e-4 |
GO:0031575 | mitotic cell cycle G1/S transition checkpoint | 1.553433e-4 |
GO:0044332 | Wnt receptor signaling pathway involved in dorsal/ventral axis specification | 1.562475e-4 |
GO:0006333 | chromatin assembly or disassembly | 1.645833e-4 |
GO:0072395 | signal transduction involved in cell cycle checkpoint | 1.763131e-4 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.776218e-4 |
GO:0070814 | hydrogen sulfide biosynthetic process | 1.785170e-4 |
GO:0070079 | histone H4-R3 demethylation | 1.845981e-4 |
GO:0070078 | histone H3-R2 demethylation | 1.845981e-4 |
GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 1.845981e-4 |
GO:0035279 | mRNA cleavage involved in gene silencing by miRNA | 1.880287e-4 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.896465e-4 |
GO:0043249 | erythrocyte maturation | 1.899344e-4 |
GO:0045736 | negative regulation of cyclin-dependent protein kinase activity | 1.919151e-4 |
GO:0070671 | response to interleukin-12 | 1.964962e-4 |
GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 2.019412e-4 |
GO:0007031 | peroxisome organization | 2.041505e-4 |
GO:0034063 | stress granule assembly | 2.082529e-4 |
GO:0007339 | binding of sperm to zona pellucida | 2.189715e-4 |
GO:0055107 | Golgi to secretory granule transport | 2.274686e-4 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 2.318327e-4 |
GO:0015887 | pantothenate transmembrane transport | 2.329301e-4 |
GO:0015878 | biotin transport | 2.329301e-4 |
GO:0070986 | left/right axis specification | 2.427837e-4 |
GO:0018872 | arsonoacetate metabolic process | 2.459977e-4 |
GO:0031103 | axon regeneration | 2.496405e-4 |
GO:0032700 | negative regulation of interleukin-17 production | 2.646527e-4 |
GO:0046128 | purine ribonucleoside metabolic process | 2.738417e-4 |
GO:0035329 | hippo signaling cascade | 2.756941e-4 |
GO:0090083 | regulation of inclusion body assembly | 2.800277e-4 |
GO:0002860 | positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 2.902848e-4 |
GO:0031638 | zymogen activation | 2.925238e-4 |
GO:0010455 | positive regulation of cell fate commitment | 2.925238e-4 |
GO:0006268 | DNA unwinding involved in replication | 2.925238e-4 |
GO:0072422 | signal transduction involved in DNA damage checkpoint | 3.076841e-4 |
GO:0006481 | C-terminal protein methylation | 3.157027e-4 |
GO:0044237 | cellular metabolic process | 3.179329e-4 |
GO:0010507 | negative regulation of autophagy | 3.345109e-4 |
GO:0050652 | dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 3.520559e-4 |
GO:0090138 | regulation of actin cytoskeleton organization by cell-cell adhesion | 3.520559e-4 |
GO:0035409 | histone H3-Y41 phosphorylation | 3.616114e-4 |
GO:0008636 | activation of caspase activity by protein phosphorylation | 3.616114e-4 |
GO:0035771 | interleukin-4-mediated signaling pathway | 3.682396e-4 |
GO:0050691 | regulation of defense response to virus by host | 3.935261e-4 |
GO:0060286 | flagellar cell motility | 3.945061e-4 |
GO:0001555 | oocyte growth | 3.945061e-4 |
GO:0043471 | regulation of cellular carbohydrate catabolic process | 4.030640e-4 |
GO:0048280 | vesicle fusion with Golgi apparatus | 4.047235e-4 |
GO:0071415 | cellular response to purine-containing compound | 4.110780e-4 |
GO:0051383 | kinetochore organization | 4.125364e-4 |
GO:0000075 | cell cycle checkpoint | 4.151692e-4 |
GO:0051438 | regulation of ubiquitin-protein ligase activity | 4.188790e-4 |
GO:0010824 | regulation of centrosome duplication | 4.239213e-4 |
GO:0090084 | negative regulation of inclusion body assembly | 4.311388e-4 |
GO:0021587 | cerebellum morphogenesis | 4.498727e-4 |
GO:0034641 | cellular nitrogen compound metabolic process | 4.537576e-4 |
GO:0070647 | protein modification by small protein conjugation or removal | 4.597454e-4 |
GO:0006281 | DNA repair | 4.822696e-4 |
GO:0015671 | oxygen transport | 4.872318e-4 |
GO:0009956 | radial pattern formation | 4.941545e-4 |
GO:0061084 | negative regulation of protein refolding | 4.941545e-4 |
GO:0009992 | cellular water homeostasis | 5.039700e-4 |
GO:0016567 | protein ubiquitination | 5.123176e-4 |
GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway | 5.285851e-4 |
GO:0006807 | nitrogen compound metabolic process | 5.408140e-4 |
GO:0046796 | viral genome transport in host cell | 5.434777e-4 |
GO:0046314 | phosphocreatine biosynthetic process | 5.435998e-4 |
GO:0010734 | negative regulation of protein glutathionylation | 5.441229e-4 |
GO:0050687 | negative regulation of defense response to virus | 5.648335e-4 |
GO:0060981 | cell migration involved in coronary angiogenesis | 6.398399e-4 |
GO:0071670 | smooth muscle cell chemotaxis | 6.398399e-4 |
GO:0060823 | canonical Wnt receptor signaling pathway involved in neural plate anterior/posterior pattern formation | 6.398399e-4 |
GO:0001575 | globoside metabolic process | 6.398399e-4 |
GO:0035752 | lysosomal lumen pH elevation | 6.398399e-4 |
GO:0000046 | autophagic vacuole fusion | 6.398399e-4 |
GO:0006413 | translational initiation | 6.539170e-4 |
GO:0006119 | oxidative phosphorylation | 6.622669e-4 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 6.718403e-4 |
GO:0042278 | purine nucleoside metabolic process | 7.139472e-4 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 7.151121e-4 |
GO:0000278 | mitotic cell cycle | 7.306630e-4 |
GO:0051148 | negative regulation of muscle cell differentiation | 7.328796e-4 |
GO:0043380 | regulation of memory T cell differentiation | 7.485864e-4 |
GO:0010624 | regulation of Schwann cell proliferation | 7.525882e-4 |
GO:0021797 | forebrain anterior/posterior pattern specification | 7.578937e-4 |
GO:0060687 | regulation of branching involved in prostate gland morphogenesis | 7.864416e-4 |
GO:0010822 | positive regulation of mitochondrion organization | 7.899378e-4 |
GO:0042976 | activation of Janus kinase activity | 8.051360e-4 |
GO:0090197 | positive regulation of chemokine secretion | 8.185544e-4 |
GO:0060836 | lymphatic endothelial cell differentiation | 8.237307e-4 |
GO:0060419 | heart growth | 8.295112e-4 |
GO:0032479 | regulation of type I interferon production | 8.351309e-4 |
GO:2000573 | positive regulation of DNA biosynthetic process | 8.862030e-4 |
GO:0070936 | protein K48-linked ubiquitination | 8.898741e-4 |
GO:0035036 | sperm-egg recognition | 8.913654e-4 |
GO:0033630 | positive regulation of cell adhesion mediated by integrin | 9.124198e-4 |
GO:0045653 | negative regulation of megakaryocyte differentiation | 9.399324e-4 |
GO:0000472 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 9.837911e-4 |
GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 9.837911e-4 |
GO:0034401 | regulation of transcription by chromatin organization | 1.005955e-3 |
GO:0034728 | nucleosome organization | 1.025777e-3 |
GO:0009436 | glyoxylate catabolic process | 1.031745e-3 |
GO:0043308 | eosinophil degranulation | 1.062559e-3 |
GO:0009234 | menaquinone biosynthetic process | 1.062559e-3 |
GO:0030827 | negative regulation of cGMP biosynthetic process | 1.062559e-3 |
GO:0034695 | response to prostaglandin E stimulus | 1.069767e-3 |
GO:0051568 | histone H3-K4 methylation | 1.079552e-3 |
GO:0046984 | regulation of hemoglobin biosynthetic process | 1.106714e-3 |
GO:0046129 | purine ribonucleoside biosynthetic process | 1.106777e-3 |
GO:0051329 | interphase of mitotic cell cycle | 1.157727e-3 |
GO:0043392 | negative regulation of DNA binding | 1.188583e-3 |
GO:0007498 | mesoderm development | 1.199193e-3 |
GO:0070417 | cellular response to cold | 1.232850e-3 |
GO:0042396 | phosphagen biosynthetic process | 1.239788e-3 |
GO:0032275 | luteinizing hormone secretion | 1.297149e-3 |
GO:0046884 | follicle-stimulating hormone secretion | 1.297149e-3 |
GO:0032785 | negative regulation of transcription elongation, DNA-dependent | 1.309938e-3 |
GO:0002711 | positive regulation of T cell mediated immunity | 1.318723e-3 |
GO:0051301 | cell division | 1.330112e-3 |
GO:0046605 | regulation of centrosome cycle | 1.342621e-3 |
GO:0042373 | vitamin K metabolic process | 1.343216e-3 |
GO:0009411 | response to UV | 1.407301e-3 |
GO:0051028 | mRNA transport | 1.423881e-3 |
GO:0016242 | negative regulation of macroautophagy | 1.448142e-3 |
GO:0070060 | 'de novo' actin filament nucleation | 1.448142e-3 |
GO:0032648 | regulation of interferon-beta production | 1.483431e-3 |
GO:0031497 | chromatin assembly | 1.513584e-3 |
GO:0048024 | regulation of nuclear mRNA splicing, via spliceosome | 1.562175e-3 |
GO:0060242 | contact inhibition | 1.601298e-3 |
GO:0034723 | DNA replication-dependent nucleosome organization | 1.601298e-3 |
GO:0046500 | S-adenosylmethionine metabolic process | 1.607765e-3 |
GO:0050684 | regulation of mRNA processing | 1.608205e-3 |
GO:0043984 | histone H4-K16 acetylation | 1.614718e-3 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.635458e-3 |
GO:0001840 | neural plate development | 1.635971e-3 |
GO:0006334 | nucleosome assembly | 1.662678e-3 |
GO:0071824 | protein-DNA complex subunit organization | 1.670189e-3 |
GO:0031023 | microtubule organizing center organization | 1.703270e-3 |
GO:0001920 | negative regulation of receptor recycling | 1.760950e-3 |
GO:0060972 | left/right pattern formation | 1.775176e-3 |
GO:0071233 | cellular response to leucine | 1.775238e-3 |
GO:0042772 | DNA damage response, signal transduction resulting in transcription | 1.786713e-3 |
GO:0016570 | histone modification | 1.798571e-3 |
GO:0007009 | plasma membrane organization | 1.810806e-3 |
GO:0008630 | DNA damage response, signal transduction resulting in induction of apoptosis | 1.824842e-3 |
GO:0033632 | regulation of cell-cell adhesion mediated by integrin | 1.836859e-3 |
GO:0051340 | regulation of ligase activity | 1.841877e-3 |
GO:0090196 | regulation of chemokine secretion | 1.843549e-3 |
GO:0009116 | nucleoside metabolic process | 1.866844e-3 |
GO:0060648 | mammary gland bud morphogenesis | 1.878739e-3 |
GO:0032446 | protein modification by small protein conjugation | 1.906286e-3 |
GO:0033148 | positive regulation of estrogen receptor signaling pathway | 1.936720e-3 |
GO:0010626 | negative regulation of Schwann cell proliferation | 1.950886e-3 |
GO:0051325 | interphase | 1.982992e-3 |
GO:0006403 | RNA localization | 2.030992e-3 |
GO:0051276 | chromosome organization | 2.041796e-3 |
GO:0060038 | cardiac muscle cell proliferation | 2.048121e-3 |
GO:0071954 | chemokine (C-C motif) ligand 11 production | 2.055747e-3 |
GO:2000525 | positive regulation of T cell costimulation | 2.055747e-3 |
GO:0002215 | defense response to nematode | 2.055747e-3 |
GO:0035712 | T-helper 2 cell activation | 2.055747e-3 |
GO:0035709 | memory T cell activation | 2.055747e-3 |
GO:0035708 | interleukin-4-dependent isotype switching to IgE isotypes | 2.055747e-3 |
GO:0009950 | dorsal/ventral axis specification | 2.056779e-3 |
GO:0060973 | cell migration involved in heart development | 2.078230e-3 |
GO:0070103 | regulation of interleukin-6-mediated signaling pathway | 2.093092e-3 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 2.129784e-3 |
GO:0072348 | sulfur compound transport | 2.146722e-3 |
GO:0001914 | regulation of T cell mediated cytotoxicity | 2.176565e-3 |
GO:0034645 | cellular macromolecule biosynthetic process | 2.181547e-3 |
GO:0006405 | RNA export from nucleus | 2.190764e-3 |
GO:0060399 | positive regulation of growth hormone receptor signaling pathway | 2.209289e-3 |
GO:0046108 | uridine metabolic process | 2.209289e-3 |
GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin | 2.236040e-3 |
GO:0042398 | cellular modified amino acid biosynthetic process | 2.260858e-3 |
GO:0002067 | glandular epithelial cell differentiation | 2.281237e-3 |
GO:0015910 | peroxisomal long-chain fatty acid import | 2.315172e-3 |
GO:0016569 | covalent chromatin modification | 2.348495e-3 |
GO:0022618 | ribonucleoprotein complex assembly | 2.371052e-3 |
GO:0048320 | axial mesoderm formation | 2.382307e-3 |
GO:0060921 | sinoatrial node cell differentiation | 2.526629e-3 |
GO:0060975 | cardioblast migration to the midline involved in heart field formation | 2.526629e-3 |
GO:0042664 | negative regulation of endodermal cell fate specification | 2.526629e-3 |
GO:0071799 | cellular response to prostaglandin D stimulus | 2.526629e-3 |
GO:0003236 | sinus venosus morphogenesis | 2.526629e-3 |
GO:0003210 | cardiac atrium formation | 2.526629e-3 |
GO:0035481 | positive regulation of Notch signaling pathway involved in heart induction | 2.526629e-3 |
GO:0003241 | growth involved in heart morphogenesis | 2.526629e-3 |
GO:0003259 | cardioblast anterior-lateral migration | 2.526629e-3 |
GO:0051444 | negative regulation of ubiquitin-protein ligase activity | 2.537170e-3 |
GO:0035881 | amacrine cell differentiation | 2.621034e-3 |
GO:0019344 | cysteine biosynthetic process | 2.766599e-3 |
GO:0051252 | regulation of RNA metabolic process | 2.814916e-3 |
GO:0051454 | intracellular pH elevation | 2.830152e-3 |
GO:0042771 | DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis | 2.884129e-3 |
GO:2000249 | regulation of actin cytoskeleton reorganization | 2.897319e-3 |
GO:0051135 | positive regulation of NK T cell activation | 2.900701e-3 |
GO:0006098 | pentose-phosphate shunt | 2.974870e-3 |
GO:0034048 | negative regulation of protein phosphatase type 2A activity | 2.985678e-3 |
GO:0060649 | mammary gland bud elongation | 3.056451e-3 |
GO:0060659 | nipple sheath formation | 3.056451e-3 |
GO:0034660 | ncRNA metabolic process | 3.237417e-3 |
GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 3.266330e-3 |
GO:0006683 | galactosylceramide catabolic process | 3.283801e-3 |
GO:0035372 | protein localization to microtubule | 3.283801e-3 |
GO:0002051 | osteoblast fate commitment | 3.318422e-3 |
GO:0032329 | serine transport | 3.331759e-3 |
GO:0042088 | T-helper 1 type immune response | 3.335155e-3 |
GO:0042832 | defense response to protozoan | 3.344409e-3 |
GO:0018205 | peptidyl-lysine modification | 3.366975e-3 |
GO:0034968 | histone lysine methylation | 3.412159e-3 |
GO:0071156 | regulation of cell cycle arrest | 3.416084e-3 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 3.434392e-3 |
GO:0009303 | rRNA transcription | 3.460951e-3 |
GO:0060124 | positive regulation of growth hormone secretion | 3.490147e-3 |
GO:0046599 | regulation of centriole replication | 3.597092e-3 |
GO:0003002 | regionalization | 3.660291e-3 |
GO:0006189 | 'de novo' IMP biosynthetic process | 3.763033e-3 |
GO:0042775 | mitochondrial ATP synthesis coupled electron transport | 3.774907e-3 |
GO:0010610 | regulation of mRNA stability involved in response to stress | 3.795213e-3 |
GO:0009231 | riboflavin biosynthetic process | 3.795213e-3 |
GO:0006974 | response to DNA damage stimulus | 3.818179e-3 |
GO:0006386 | termination of RNA polymerase III transcription | 3.826805e-3 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 3.826805e-3 |
GO:0051583 | dopamine uptake | 3.872953e-3 |
GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway | 4.011040e-3 |
GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter | 4.027110e-3 |
GO:0000079 | regulation of cyclin-dependent protein kinase activity | 4.037674e-3 |
GO:0019693 | ribose phosphate metabolic process | 4.062799e-3 |
GO:0006463 | steroid hormone receptor complex assembly | 4.096976e-3 |
GO:0090007 | regulation of mitotic anaphase | 4.148279e-3 |
GO:0051488 | activation of anaphase-promoting complex activity | 4.155385e-3 |
GO:0042506 | tyrosine phosphorylation of Stat5 protein | 4.155385e-3 |
GO:0016573 | histone acetylation | 4.174229e-3 |
GO:0033628 | regulation of cell adhesion mediated by integrin | 4.183277e-3 |
GO:0010660 | regulation of muscle cell apoptosis | 4.233965e-3 |
GO:0031398 | positive regulation of protein ubiquitination | 4.292881e-3 |
GO:0033145 | positive regulation of steroid hormone receptor signaling pathway | 4.308098e-3 |
GO:0001839 | neural plate morphogenesis | 4.381822e-3 |
GO:0040015 | negative regulation of multicellular organism growth | 4.387886e-3 |
GO:0009059 | macromolecule biosynthetic process | 4.501488e-3 |
GO:0035196 | production of miRNAs involved in gene silencing by miRNA | 4.538273e-3 |
GO:0002230 | positive regulation of defense response to virus by host | 4.642215e-3 |
GO:0006825 | copper ion transport | 4.642864e-3 |
GO:0006681 | galactosylceramide metabolic process | 4.680322e-3 |
GO:0010715 | regulation of extracellular matrix disassembly | 4.693033e-3 |
GO:0000422 | mitochondrion degradation | 4.711431e-3 |
GO:0009119 | ribonucleoside metabolic process | 4.883497e-3 |
GO:0070358 | actin polymerization-dependent cell motility | 4.974740e-3 |
GO:0060058 | positive regulation of apoptosis involved in mammary gland involution | 4.978485e-3 |
GO:0035089 | establishment of apical/basal cell polarity | 5.159540e-3 |
GO:0090399 | replicative senescence | 5.167855e-3 |
GO:0001562 | response to protozoan | 5.181786e-3 |
GO:0048384 | retinoic acid receptor signaling pathway | 5.234736e-3 |
GO:0007093 | mitotic cell cycle checkpoint | 5.263710e-3 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 5.302790e-3 |
GO:0051169 | nuclear transport | 5.307243e-3 |
GO:0060235 | lens induction in camera-type eye | 5.356107e-3 |
GO:0051154 | negative regulation of striated muscle cell differentiation | 5.393819e-3 |
GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process | 5.395125e-3 |
GO:0090344 | negative regulation of cell aging | 5.422267e-3 |
GO:0033146 | regulation of estrogen receptor signaling pathway | 5.448419e-3 |
GO:0032816 | positive regulation of natural killer cell activation | 5.448419e-3 |
GO:0055017 | cardiac muscle tissue growth | 5.499484e-3 |
GO:0071353 | cellular response to interleukin-4 | 5.648301e-3 |
GO:0017121 | phospholipid scrambling | 5.677251e-3 |
GO:0014060 | regulation of epinephrine secretion | 5.688781e-3 |
GO:0003219 | cardiac right ventricle formation | 5.688781e-3 |
GO:0071826 | ribonucleoprotein complex subunit organization | 5.738011e-3 |
GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process | 5.902499e-3 |
GO:0000088 | mitotic prophase | 5.902499e-3 |
GO:0035195 | gene silencing by miRNA | 5.952832e-3 |
GO:0032876 | negative regulation of DNA endoreduplication | 6.083662e-3 |
GO:0006110 | regulation of glycolysis | 6.102687e-3 |
GO:0006913 | nucleocytoplasmic transport | 6.104982e-3 |
GO:0046952 | ketone body catabolic process | 6.136440e-3 |
GO:0044273 | sulfur compound catabolic process | 6.153033e-3 |
GO:0042363 | fat-soluble vitamin catabolic process | 6.180540e-3 |
GO:0046950 | cellular ketone body metabolic process | 6.203828e-3 |
GO:0006868 | glutamine transport | 6.203828e-3 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 6.230215e-3 |
GO:0007509 | mesoderm migration involved in gastrulation | 6.235582e-3 |
GO:0006298 | mismatch repair | 6.359135e-3 |
GO:0042727 | flavin-containing compound biosynthetic process | 6.392163e-3 |
GO:0001830 | trophectodermal cell fate commitment | 6.392163e-3 |
GO:0034314 | Arp2/3 complex-mediated actin nucleation | 6.392163e-3 |
GO:0045793 | positive regulation of cell size | 6.493870e-3 |
GO:0065004 | protein-DNA complex assembly | 6.516658e-3 |
GO:0040040 | thermosensory behavior | 6.661182e-3 |
GO:0051168 | nuclear export | 6.665112e-3 |
GO:0006206 | pyrimidine base metabolic process | 6.673129e-3 |
GO:0051182 | coenzyme transport | 6.750930e-3 |
GO:0000080 | G1 phase of mitotic cell cycle | 6.860748e-3 |
GO:0016571 | histone methylation | 6.898084e-3 |
GO:0032811 | negative regulation of epinephrine secretion | 6.899179e-3 |
GO:0035265 | organ growth | 6.961623e-3 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 6.977311e-3 |
GO:0006565 | L-serine catabolic process | 6.990212e-3 |
GO:0000715 | nucleotide-excision repair, DNA damage recognition | 7.078392e-3 |
GO:0009948 | anterior/posterior axis specification | 7.104494e-3 |
GO:0042723 | thiamine-containing compound metabolic process | 7.482825e-3 |
GO:0018065 | protein-cofactor linkage | 7.508391e-3 |
GO:0006355 | regulation of transcription, DNA-dependent | 7.517115e-3 |
GO:0051297 | centrosome organization | 7.584535e-3 |
GO:0018394 | peptidyl-lysine acetylation | 7.588391e-3 |
GO:0042093 | T-helper cell differentiation | 7.623723e-3 |
GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus | 7.629009e-3 |
GO:0007253 | cytoplasmic sequestering of NF-kappaB | 7.692825e-3 |
GO:0048368 | lateral mesoderm development | 7.703619e-3 |
GO:0006740 | NADPH regeneration | 7.800377e-3 |
GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment | 7.862849e-3 |
GO:0046951 | ketone body biosynthetic process | 7.911793e-3 |
GO:0042637 | catagen | 7.911793e-3 |
GO:0032383 | regulation of intracellular cholesterol transport | 7.916157e-3 |
GO:0070918 | production of small RNA involved in gene silencing by RNA | 7.923203e-3 |
GO:0042418 | epinephrine biosynthetic process | 8.004614e-3 |
GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA | 8.004614e-3 |
GO:0021933 | radial glia guided migration of cerebellar granule cell | 8.004614e-3 |
GO:0006585 | dopamine biosynthetic process from tyrosine | 8.004614e-3 |
GO:0043170 | macromolecule metabolic process | 8.025472e-3 |
GO:0060427 | lung connective tissue development | 8.070229e-3 |
GO:0032070 | regulation of deoxyribonuclease activity | 8.070229e-3 |
GO:0015680 | intracellular copper ion transport | 8.070229e-3 |
GO:0032474 | otolith morphogenesis | 8.088591e-3 |
GO:0031119 | tRNA pseudouridine synthesis | 8.088591e-3 |
GO:0060398 | regulation of growth hormone receptor signaling pathway | 8.125354e-3 |
GO:0043585 | nose morphogenesis | 8.176199e-3 |
GO:0030823 | regulation of cGMP metabolic process | 8.217229e-3 |
GO:0060206 | estrous cycle phase | 8.217229e-3 |
GO:0060711 | labyrinthine layer development | 8.236531e-3 |
GO:0051382 | kinetochore assembly | 8.339304e-3 |
GO:0010700 | negative regulation of norepinephrine secretion | 8.395093e-3 |
GO:0043060 | meiotic metaphase I plate congression | 8.417001e-3 |
GO:0018393 | internal peptidyl-lysine acetylation | 8.469168e-3 |
GO:0002839 | positive regulation of immune response to tumor cell | 8.564835e-3 |
GO:0015669 | gas transport | 8.702777e-3 |
GO:0003407 | neural retina development | 8.830143e-3 |
GO:0010225 | response to UV-C | 8.874069e-3 |
GO:0034616 | response to laminar fluid shear stress | 8.972158e-3 |
GO:0045746 | negative regulation of Notch signaling pathway | 9.033177e-3 |
GO:0048593 | camera-type eye morphogenesis | 9.174008e-3 |
GO:0009637 | response to blue light | 9.223054e-3 |
GO:0021526 | medial motor column neuron differentiation | 9.284158e-3 |
GO:0008617 | guanosine metabolic process | 9.291346e-3 |
GO:0022900 | electron transport chain | 9.441861e-3 |
GO:0072331 | signal transduction by p53 class mediator | 9.632495e-3 |
GO:0090199 | regulation of release of cytochrome c from mitochondria | 9.680511e-3 |
GO:0018126 | protein hydroxylation | 9.713872e-3 |
GO:0043574 | peroxisomal transport | 9.926866e-3 |
GO:0003105 | negative regulation of glomerular filtration | 1.003072e-2 |
GO:2000104 | negative regulation of DNA-dependent DNA replication | 1.005189e-2 |
GO:0000244 | assembly of spliceosomal tri-snRNP | 1.007964e-2 |
GO:0032660 | regulation of interleukin-17 production | 1.010142e-2 |
GO:0070389 | chaperone cofactor-dependent protein refolding | 1.018234e-2 |
GO:0048554 | positive regulation of metalloenzyme activity | 1.030734e-2 |
GO:0045819 | positive regulation of glycogen catabolic process | 1.056164e-2 |
GO:0032594 | protein transport within lipid bilayer | 1.056282e-2 |
GO:0010800 | positive regulation of peptidyl-threonine phosphorylation | 1.058932e-2 |
GO:0043543 | protein acylation | 1.072990e-2 |
GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis | 1.074477e-2 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 1.074477e-2 |
GO:0061302 | smooth muscle cell-matrix adhesion | 1.074477e-2 |
GO:0033483 | gas homeostasis | 1.087875e-2 |
GO:0090201 | negative regulation of release of cytochrome c from mitochondria | 1.098399e-2 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.127590e-2 |
GO:0060576 | intestinal epithelial cell development | 1.133267e-2 |
GO:0010002 | cardioblast differentiation | 1.144196e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0090304 | nucleic acid metabolic process | 5.126838e-11 |
GO:0045653 | negative regulation of megakaryocyte differentiation | 5.198810e-11 |
GO:0010467 | gene expression | 3.231668e-10 |
GO:0048743 | positive regulation of skeletal muscle fiber development | 6.859343e-10 |
GO:0043001 | Golgi to plasma membrane protein transport | 3.734501e-9 |
GO:0015966 | diadenosine tetraphosphate biosynthetic process | 4.857078e-9 |
GO:0016070 | RNA metabolic process | 1.253623e-8 |
GO:0051028 | mRNA transport | 1.279973e-8 |
GO:0006139 | nucleobase-containing compound metabolic process | 2.052973e-8 |
GO:0006893 | Golgi to plasma membrane transport | 5.665356e-8 |
GO:0008612 | peptidyl-lysine modification to hypusine | 9.152360e-8 |
GO:0034227 | tRNA thio-modification | 1.017094e-7 |
GO:0044260 | cellular macromolecule metabolic process | 1.652809e-7 |
GO:0034337 | RNA folding | 1.857218e-7 |
GO:0006403 | RNA localization | 2.686574e-7 |
GO:0044029 | hypomethylation of CpG island | 5.387475e-7 |
GO:0002098 | tRNA wobble uridine modification | 7.912505e-7 |
GO:0034641 | cellular nitrogen compound metabolic process | 9.749608e-7 |
GO:0033617 | mitochondrial respiratory chain complex IV assembly | 1.153363e-6 |
GO:0048239 | negative regulation of DNA recombination at telomere | 1.153363e-6 |
GO:0006430 | lysyl-tRNA aminoacylation | 1.153363e-6 |
GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell | 1.269130e-6 |
GO:0006892 | post-Golgi vesicle-mediated transport | 1.366587e-6 |
GO:0006651 | diacylglycerol biosynthetic process | 1.598232e-6 |
GO:0010631 | epithelial cell migration | 1.767288e-6 |
GO:0006306 | DNA methylation | 2.258096e-6 |
GO:0048193 | Golgi vesicle transport | 2.258626e-6 |
GO:2000279 | negative regulation of DNA biosynthetic process | 2.642127e-6 |
GO:0045905 | positive regulation of translational termination | 2.674782e-6 |
GO:0006452 | translational frameshifting | 2.674782e-6 |
GO:0045901 | positive regulation of translational elongation | 2.674782e-6 |
GO:0070078 | histone H3-R2 demethylation | 2.873655e-6 |
GO:0070079 | histone H4-R3 demethylation | 2.873655e-6 |
GO:0022417 | protein maturation by protein folding | 2.873655e-6 |
GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity | 2.873655e-6 |
GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 2.873655e-6 |
GO:0033591 | response to L-ascorbic acid | 3.063399e-6 |
GO:0045746 | negative regulation of Notch signaling pathway | 3.201229e-6 |
GO:0050658 | RNA transport | 3.266777e-6 |
GO:0010288 | response to lead ion | 5.574610e-6 |
GO:0001892 | embryonic placenta development | 6.513981e-6 |
GO:0006449 | regulation of translational termination | 8.420187e-6 |
GO:0034101 | erythrocyte homeostasis | 8.871155e-6 |
GO:0006807 | nitrogen compound metabolic process | 9.171446e-6 |
GO:2000278 | regulation of DNA biosynthetic process | 9.299690e-6 |
GO:0045652 | regulation of megakaryocyte differentiation | 1.223368e-5 |
GO:0044030 | regulation of DNA methylation | 1.288600e-5 |
GO:0048643 | positive regulation of skeletal muscle tissue development | 1.327712e-5 |
GO:0034728 | nucleosome organization | 1.570337e-5 |
GO:0006396 | RNA processing | 1.703314e-5 |
GO:0045585 | positive regulation of cytotoxic T cell differentiation | 1.961401e-5 |
GO:0032693 | negative regulation of interleukin-10 production | 1.998869e-5 |
GO:0016071 | mRNA metabolic process | 2.363188e-5 |
GO:0006397 | mRNA processing | 2.497744e-5 |
GO:0006334 | nucleosome assembly | 2.926139e-5 |
GO:0090130 | tissue migration | 3.115190e-5 |
GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway | 3.201980e-5 |
GO:0019348 | dolichol metabolic process | 3.265081e-5 |
GO:0001832 | blastocyst growth | 3.273569e-5 |
GO:0015959 | diadenosine polyphosphate metabolic process | 3.290532e-5 |
GO:0030218 | erythrocyte differentiation | 3.471562e-5 |
GO:0002678 | positive regulation of chronic inflammatory response | 3.487782e-5 |
GO:0006448 | regulation of translational elongation | 3.944523e-5 |
GO:0000079 | regulation of cyclin-dependent protein kinase activity | 4.282613e-5 |
GO:0051131 | chaperone-mediated protein complex assembly | 4.378154e-5 |
GO:0006402 | mRNA catabolic process | 4.695266e-5 |
GO:0040019 | positive regulation of embryonic development | 4.708490e-5 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 4.911621e-5 |
GO:0072355 | histone H3-T3 phosphorylation | 5.468101e-5 |
GO:0042703 | menstruation | 5.468101e-5 |
GO:0019101 | female somatic sex determination | 5.468101e-5 |
GO:0006259 | DNA metabolic process | 5.672984e-5 |
GO:0065004 | protein-DNA complex assembly | 5.918210e-5 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 6.474364e-5 |
GO:0046339 | diacylglycerol metabolic process | 6.506837e-5 |
GO:0016578 | histone deubiquitination | 6.689603e-5 |
GO:0009296 | flagellum assembly | 6.689603e-5 |
GO:0071103 | DNA conformation change | 6.974566e-5 |
GO:0006351 | transcription, DNA-dependent | 8.231168e-5 |
GO:0090138 | regulation of actin cytoskeleton organization by cell-cell adhesion | 8.423515e-5 |
GO:0051901 | positive regulation of mitochondrial depolarization | 8.618252e-5 |
GO:0032774 | RNA biosynthetic process | 9.750826e-5 |
GO:0009956 | radial pattern formation | 9.949842e-5 |
GO:0032205 | negative regulation of telomere maintenance | 1.105140e-4 |
GO:0045844 | positive regulation of striated muscle tissue development | 1.106350e-4 |
GO:0032274 | gonadotropin secretion | 1.111073e-4 |
GO:0051661 | maintenance of centrosome location | 1.164113e-4 |
GO:0090086 | negative regulation of protein deubiquitination | 1.218419e-4 |
GO:0006323 | DNA packaging | 1.338314e-4 |
GO:0008593 | regulation of Notch signaling pathway | 1.387233e-4 |
GO:0006507 | GPI anchor release | 1.425016e-4 |
GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process | 1.425016e-4 |
GO:0006304 | DNA modification | 1.567227e-4 |
GO:0043064 | flagellum organization | 1.836844e-4 |
GO:0060711 | labyrinthine layer development | 2.126103e-4 |
GO:0048024 | regulation of nuclear mRNA splicing, via spliceosome | 2.215461e-4 |
GO:0034276 | kynurenic acid biosynthetic process | 2.396136e-4 |
GO:0019046 | reactivation of latent virus | 2.396136e-4 |
GO:0002534 | cytokine production involved in inflammatory response | 2.396136e-4 |
GO:0000027 | ribosomal large subunit assembly | 2.396136e-4 |
GO:0042218 | 1-aminocyclopropane-1-carboxylate biosynthetic process | 2.413211e-4 |
GO:0001913 | T cell mediated cytotoxicity | 2.505333e-4 |
GO:0071824 | protein-DNA complex subunit organization | 2.540401e-4 |
GO:0072498 | embryonic skeletal joint development | 2.727783e-4 |
GO:0043048 | dolichyl monophosphate biosynthetic process | 2.737419e-4 |
GO:0072334 | UDP-galactose transmembrane transport | 2.737419e-4 |
GO:0000244 | assembly of spliceosomal tri-snRNP | 2.737419e-4 |
GO:0031497 | chromatin assembly | 3.051971e-4 |
GO:0006626 | protein targeting to mitochondrion | 3.091032e-4 |
GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway | 3.111116e-4 |
GO:0051155 | positive regulation of striated muscle cell differentiation | 3.112731e-4 |
GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway | 3.162935e-4 |
GO:0043484 | regulation of RNA splicing | 3.182391e-4 |
GO:0035137 | hindlimb morphogenesis | 3.343712e-4 |
GO:0046929 | negative regulation of neurotransmitter secretion | 3.468844e-4 |
GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide | 3.468844e-4 |
GO:0007288 | sperm axoneme assembly | 3.615072e-4 |
GO:0046626 | regulation of insulin receptor signaling pathway | 3.638489e-4 |
GO:0034645 | cellular macromolecule biosynthetic process | 3.649841e-4 |
GO:0016068 | type I hypersensitivity | 3.822474e-4 |
GO:0031057 | negative regulation of histone modification | 4.339762e-4 |
GO:0003310 | pancreatic A cell differentiation | 4.480112e-4 |
GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c | 4.707702e-4 |
GO:0006888 | ER to Golgi vesicle-mediated transport | 4.870913e-4 |
GO:0000415 | negative regulation of histone H3-K36 methylation | 4.956382e-4 |
GO:0035269 | protein O-linked mannosylation | 4.956382e-4 |
GO:0031576 | G2/M transition checkpoint | 5.031056e-4 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 5.050660e-4 |
GO:0042694 | muscle cell fate specification | 5.050660e-4 |
GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 5.131882e-4 |
GO:0060024 | rhythmic synaptic transmission | 5.131882e-4 |
GO:0090212 | negative regulation of establishment of blood-brain barrier | 5.302002e-4 |
GO:0015969 | guanosine tetraphosphate metabolic process | 5.302002e-4 |
GO:0002638 | negative regulation of immunoglobulin production | 5.302002e-4 |
GO:0001811 | negative regulation of type I hypersensitivity | 5.302002e-4 |
GO:0009059 | macromolecule biosynthetic process | 5.454806e-4 |
GO:0060272 | embryonic skeletal joint morphogenesis | 5.902485e-4 |
GO:0006401 | RNA catabolic process | 5.904242e-4 |
GO:0030101 | natural killer cell activation | 5.985654e-4 |
GO:0000722 | telomere maintenance via recombination | 6.201983e-4 |
GO:0043170 | macromolecule metabolic process | 6.267330e-4 |
GO:0008380 | RNA splicing | 6.441836e-4 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 6.616956e-4 |
GO:0006325 | chromatin organization | 6.655615e-4 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 6.851489e-4 |
GO:0090288 | negative regulation of cellular response to growth factor stimulus | 7.488748e-4 |
GO:0060710 | chorio-allantoic fusion | 7.585860e-4 |
GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment | 7.846131e-4 |
GO:0051276 | chromosome organization | 8.179736e-4 |
GO:0030719 | P granule organization | 8.229217e-4 |
GO:0002763 | positive regulation of myeloid leukocyte differentiation | 8.726414e-4 |
GO:0034551 | mitochondrial respiratory chain complex III assembly | 9.539594e-4 |
GO:0018993 | somatic sex determination | 9.539594e-4 |
GO:0050886 | endocrine process | 9.958939e-4 |
GO:0070086 | ubiquitin-dependent endocytosis | 1.005719e-3 |
GO:0019858 | cytosine metabolic process | 1.005719e-3 |
GO:0097151 | positive regulation of inhibitory postsynaptic membrane potential | 1.005719e-3 |
GO:0001966 | thigmotaxis | 1.005719e-3 |
GO:0007630 | jump response | 1.005719e-3 |
GO:0009637 | response to blue light | 1.005719e-3 |
GO:0034619 | cellular chaperone-mediated protein complex assembly | 1.006141e-3 |
GO:0021750 | vestibular nucleus development | 1.006141e-3 |
GO:0021590 | cerebellum maturation | 1.006141e-3 |
GO:0021679 | cerebellar molecular layer development | 1.006141e-3 |
GO:0060839 | endothelial cell fate commitment | 1.020159e-3 |
GO:0035082 | axoneme assembly | 1.020159e-3 |
GO:0072249 | metanephric glomerular visceral epithelial cell development | 1.041658e-3 |
GO:0048677 | axon extension involved in regeneration | 1.041658e-3 |
GO:0072274 | metanephric glomerular basement membrane development | 1.041658e-3 |
GO:0009443 | pyridoxal 5'-phosphate salvage | 1.041658e-3 |
GO:0045769 | negative regulation of asymmetric cell division | 1.041658e-3 |
GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity | 1.041658e-3 |
GO:0043378 | positive regulation of CD8-positive, alpha-beta T cell differentiation | 1.041658e-3 |
GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity | 1.063365e-3 |
GO:0009629 | response to gravity | 1.113777e-3 |
GO:0060850 | regulation of transcription involved in cell fate commitment | 1.129142e-3 |
GO:0060836 | lymphatic endothelial cell differentiation | 1.158464e-3 |
GO:0051568 | histone H3-K4 methylation | 1.226238e-3 |
GO:0033365 | protein localization to organelle | 1.227820e-3 |
GO:0051488 | activation of anaphase-promoting complex activity | 1.232517e-3 |
GO:0070668 | positive regulation of mast cell proliferation | 1.310994e-3 |
GO:0070171 | negative regulation of tooth mineralization | 1.310994e-3 |
GO:0018126 | protein hydroxylation | 1.355657e-3 |
GO:0072655 | establishment of protein localization in mitochondrion | 1.356301e-3 |
GO:0010225 | response to UV-C | 1.357621e-3 |
GO:0045862 | positive regulation of proteolysis | 1.397982e-3 |
GO:0060716 | labyrinthine layer blood vessel development | 1.435655e-3 |
GO:0040034 | regulation of development, heterochronic | 1.442007e-3 |
GO:0031577 | spindle checkpoint | 1.523731e-3 |
GO:0050684 | regulation of mRNA processing | 1.531061e-3 |
GO:0071353 | cellular response to interleukin-4 | 1.631549e-3 |
GO:0032908 | regulation of transforming growth factor beta1 production | 1.631549e-3 |
GO:0002676 | regulation of chronic inflammatory response | 1.704541e-3 |
GO:0021897 | forebrain astrocyte development | 1.717166e-3 |
GO:0071247 | cellular response to chromate | 1.717166e-3 |
GO:0051149 | positive regulation of muscle cell differentiation | 1.837634e-3 |
GO:0050883 | musculoskeletal movement, spinal reflex action | 1.842493e-3 |
GO:0019058 | viral infectious cycle | 1.878550e-3 |
GO:0015931 | nucleobase-containing compound transport | 1.942073e-3 |
GO:0010569 | regulation of double-strand break repair via homologous recombination | 1.958976e-3 |
GO:0040032 | post-embryonic body morphogenesis | 1.998696e-3 |
GO:0031061 | negative regulation of histone methylation | 2.003027e-3 |
GO:0040029 | regulation of gene expression, epigenetic | 2.117668e-3 |
GO:0090085 | regulation of protein deubiquitination | 2.125307e-3 |
GO:0046591 | embryonic leg joint morphogenesis | 2.125307e-3 |
GO:0006108 | malate metabolic process | 2.218313e-3 |
GO:0072141 | renal interstitial cell development | 2.218499e-3 |
GO:0048384 | retinoic acid receptor signaling pathway | 2.225641e-3 |
GO:0001881 | receptor recycling | 2.255789e-3 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.266245e-3 |
GO:0071173 | spindle assembly checkpoint | 2.281523e-3 |
GO:0071108 | protein K48-linked deubiquitination | 2.281523e-3 |
GO:0030099 | myeloid cell differentiation | 2.356264e-3 |
GO:0035094 | response to nicotine | 2.418261e-3 |
GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore | 2.477793e-3 |
GO:0000966 | RNA 5'-end processing | 2.477793e-3 |
GO:0046079 | dUMP catabolic process | 2.477793e-3 |
GO:0006412 | translation | 2.496398e-3 |
GO:0034502 | protein localization to chromosome | 2.658138e-3 |
GO:0072259 | metanephric interstitial cell development | 2.715066e-3 |
GO:0090094 | metanephric cap mesenchymal cell proliferation involved in metanephros development | 2.715066e-3 |
GO:0072208 | metanephric smooth muscle tissue development | 2.715066e-3 |
GO:0072184 | renal vesicle progenitor cell differentiation | 2.715066e-3 |
GO:0072168 | specification of anterior mesonephric tubule identity | 2.715066e-3 |
GO:0072169 | specification of posterior mesonephric tubule identity | 2.715066e-3 |
GO:0010157 | response to chlorate | 2.747487e-3 |
GO:0000414 | regulation of histone H3-K36 methylation | 2.885796e-3 |
GO:0031848 | protection from non-homologous end joining at telomere | 2.885796e-3 |
GO:0072133 | metanephric mesenchyme morphogenesis | 2.885796e-3 |
GO:0021986 | habenula development | 2.885796e-3 |
GO:0051589 | negative regulation of neurotransmitter transport | 2.944325e-3 |
GO:0046031 | ADP metabolic process | 2.944325e-3 |
GO:0014051 | gamma-aminobutyric acid secretion | 2.944325e-3 |
GO:0042147 | retrograde transport, endosome to Golgi | 3.001402e-3 |
GO:0070585 | protein localization in mitochondrion | 3.105432e-3 |
GO:0006333 | chromatin assembly or disassembly | 3.142636e-3 |
GO:0070198 | protein localization to chromosome, telomeric region | 3.149224e-3 |
GO:0055119 | relaxation of cardiac muscle | 3.149224e-3 |
GO:0006354 | transcription elongation, DNA-dependent | 3.151977e-3 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 3.205086e-3 |
GO:0008535 | respiratory chain complex IV assembly | 3.329383e-3 |
GO:0000380 | alternative nuclear mRNA splicing, via spliceosome | 3.329383e-3 |
GO:0015780 | nucleotide-sugar transport | 3.426085e-3 |
GO:0046686 | response to cadmium ion | 3.430460e-3 |
GO:0018198 | peptidyl-cysteine modification | 3.525761e-3 |
GO:0030851 | granulocyte differentiation | 3.532639e-3 |
GO:0060986 | endocrine hormone secretion | 3.549548e-3 |
GO:0031657 | regulation of cyclin-dependent protein kinase activity involved in G1/S | 3.610662e-3 |
GO:0033119 | negative regulation of RNA splicing | 3.613394e-3 |
GO:0002438 | acute inflammatory response to antigenic stimulus | 3.613394e-3 |
GO:0065001 | specification of axis polarity | 3.638560e-3 |
GO:0043951 | negative regulation of cAMP-mediated signaling | 3.638560e-3 |
GO:0035093 | spermatogenesis, exchange of chromosomal proteins | 3.638560e-3 |
GO:0021524 | visceral motor neuron differentiation | 3.685757e-3 |
GO:0021578 | hindbrain maturation | 3.715722e-3 |
GO:0001835 | blastocyst hatching | 3.715722e-3 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 3.752138e-3 |
GO:0060014 | granulosa cell differentiation | 3.863166e-3 |
GO:0070537 | histone H2A K63-linked deubiquitination | 3.863166e-3 |
GO:0006383 | transcription from RNA polymerase III promoter | 3.863166e-3 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 3.888544e-3 |
GO:0048025 | negative regulation of nuclear mRNA splicing, via spliceosome | 3.903056e-3 |
GO:0070189 | kynurenine metabolic process | 3.934447e-3 |
GO:0051865 | protein autoubiquitination | 3.947837e-3 |
GO:0007628 | adult walking behavior | 3.960382e-3 |
GO:0006473 | protein acetylation | 3.986272e-3 |
GO:0034154 | toll-like receptor 7 signaling pathway | 4.048106e-3 |
GO:0001834 | trophectodermal cell proliferation | 4.048106e-3 |
GO:0042415 | norepinephrine metabolic process | 4.056901e-3 |
GO:0000236 | mitotic prometaphase | 4.216461e-3 |
GO:0090321 | positive regulation of chylomicron remnant clearance | 4.216461e-3 |
GO:0090319 | positive regulation of chylomicron remodeling | 4.216461e-3 |
GO:0001890 | placenta development | 4.346567e-3 |
GO:0045040 | protein import into mitochondrial outer membrane | 4.357829e-3 |
GO:0035887 | aortic smooth muscle cell differentiation | 4.357829e-3 |
GO:0070536 | protein K63-linked deubiquitination | 4.371670e-3 |
GO:0000042 | protein targeting to Golgi | 4.380313e-3 |
GO:0045056 | transcytosis | 4.380313e-3 |
GO:0033160 | positive regulation of protein import into nucleus, translocation | 4.420356e-3 |
GO:0017004 | cytochrome complex assembly | 4.632365e-3 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 4.669454e-3 |
GO:0048505 | regulation of timing of cell differentiation | 4.697364e-3 |
GO:0071423 | malate transmembrane transport | 4.715973e-3 |
GO:0015709 | thiosulfate transport | 4.715973e-3 |
GO:0014005 | microglia development | 4.715973e-3 |
GO:0009159 | deoxyribonucleoside monophosphate catabolic process | 4.715973e-3 |
GO:0031572 | G2/M transition DNA damage checkpoint | 4.782045e-3 |
GO:0051252 | regulation of RNA metabolic process | 4.795612e-3 |
GO:0072183 | negative regulation of nephron tubule epithelial cell differentiation | 4.833090e-3 |
GO:0030237 | female sex determination | 4.833090e-3 |
GO:0000189 | MAPK import into nucleus | 4.833090e-3 |
GO:0051900 | regulation of mitochondrial depolarization | 4.874994e-3 |
GO:0018205 | peptidyl-lysine modification | 4.895728e-3 |
GO:0048625 | myoblast cell fate commitment | 5.017779e-3 |
GO:0060019 | radial glial cell differentiation | 5.044090e-3 |
GO:0051935 | glutamate uptake involved in synaptic transmission | 5.081887e-3 |
GO:0000281 | cytokinesis after mitosis | 5.081887e-3 |
GO:0043543 | protein acylation | 5.151289e-3 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 5.162486e-3 |
GO:0030854 | positive regulation of granulocyte differentiation | 5.232116e-3 |
GO:0051053 | negative regulation of DNA metabolic process | 5.361638e-3 |
GO:0006044 | N-acetylglucosamine metabolic process | 5.369182e-3 |
GO:0050849 | negative regulation of calcium-mediated signaling | 5.567012e-3 |
GO:0051572 | negative regulation of histone H3-K4 methylation | 5.567012e-3 |
GO:0031060 | regulation of histone methylation | 5.647048e-3 |
GO:0015816 | glycine transport | 5.654442e-3 |
GO:0045494 | photoreceptor cell maintenance | 5.721886e-3 |
GO:0030522 | intracellular receptor mediated signaling pathway | 5.773337e-3 |
GO:0002262 | myeloid cell homeostasis | 5.800674e-3 |
GO:0001522 | pseudouridine synthesis | 5.896608e-3 |
GO:0001829 | trophectodermal cell differentiation | 6.006055e-3 |
GO:0021522 | spinal cord motor neuron differentiation | 6.041564e-3 |
GO:0006422 | aspartyl-tRNA aminoacylation | 6.212487e-3 |
GO:0046356 | acetyl-CoA catabolic process | 6.228668e-3 |
GO:0030223 | neutrophil differentiation | 6.357471e-3 |
GO:0070170 | regulation of tooth mineralization | 6.357471e-3 |
GO:0060713 | labyrinthine layer morphogenesis | 6.503036e-3 |
GO:0046007 | negative regulation of activated T cell proliferation | 6.509712e-3 |
GO:0000045 | autophagic vacuole assembly | 6.553292e-3 |
GO:0018193 | peptidyl-amino acid modification | 6.663553e-3 |
GO:0016584 | nucleosome positioning | 6.694174e-3 |
GO:0010458 | exit from mitosis | 6.694174e-3 |
GO:0034621 | cellular macromolecular complex subunit organization | 6.762683e-3 |
GO:0006172 | ADP biosynthetic process | 6.770256e-3 |
GO:0045089 | positive regulation of innate immune response | 6.940818e-3 |
GO:0032204 | regulation of telomere maintenance | 7.286323e-3 |
GO:0019067 | viral assembly, maturation, egress, and release | 7.286323e-3 |
GO:0048066 | developmental pigmentation | 7.520888e-3 |
GO:0014056 | regulation of acetylcholine secretion | 7.811015e-3 |
GO:0018243 | protein O-linked glycosylation via threonine | 7.846318e-3 |
GO:0018242 | protein O-linked glycosylation via serine | 7.846318e-3 |
GO:0019408 | dolichol biosynthetic process | 7.855303e-3 |
GO:2000299 | negative regulation of Rho-dependent protein serine/threonine kinase activity | 7.855303e-3 |
GO:0032853 | positive regulation of Ran GTPase activity | 7.855303e-3 |
GO:0015887 | pantothenate transmembrane transport | 7.855303e-3 |
GO:0015878 | biotin transport | 7.855303e-3 |
GO:0000115 | regulation of transcription involved in S phase of mitotic cell cycle | 7.855303e-3 |
GO:0006427 | histidyl-tRNA aminoacylation | 7.855303e-3 |
GO:0009786 | regulation of asymmetric cell division | 7.855303e-3 |
GO:0060376 | positive regulation of mast cell differentiation | 7.898993e-3 |
GO:0072553 | terminal button organization | 7.898993e-3 |
GO:0018095 | protein polyglutamylation | 7.898993e-3 |
GO:0042360 | vitamin E metabolic process | 7.898993e-3 |
GO:0009109 | coenzyme catabolic process | 7.953047e-3 |
GO:0032911 | negative regulation of transforming growth factor beta1 production | 7.965520e-3 |
GO:0060333 | interferon-gamma-mediated signaling pathway | 8.151124e-3 |
GO:0021918 | regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment | 8.151124e-3 |
GO:0003322 | pancreatic A cell development | 8.151124e-3 |
GO:0021905 | forebrain-midbrain boundary formation | 8.151124e-3 |
GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain | 8.151124e-3 |
GO:0072594 | establishment of protein localization to organelle | 8.179716e-3 |
GO:0016572 | histone phosphorylation | 8.197770e-3 |
GO:0014002 | astrocyte development | 8.253464e-3 |
GO:0034660 | ncRNA metabolic process | 8.269155e-3 |
GO:0048821 | erythrocyte development | 8.359343e-3 |
GO:0045840 | positive regulation of mitosis | 8.572635e-3 |
GO:0001833 | inner cell mass cell proliferation | 8.642950e-3 |
GO:0051386 | regulation of nerve growth factor receptor signaling pathway | 8.746761e-3 |
GO:0030031 | cell projection assembly | 8.845723e-3 |
GO:0000413 | protein peptidyl-prolyl isomerization | 8.880063e-3 |
GO:0051457 | maintenance of protein location in nucleus | 8.920305e-3 |
GO:0060282 | positive regulation of oocyte development | 8.928508e-3 |
GO:0060281 | regulation of oocyte development | 8.928508e-3 |
GO:0000723 | telomere maintenance | 9.210463e-3 |
GO:0035195 | gene silencing by miRNA | 9.554659e-3 |
GO:0021520 | spinal cord motor neuron cell fate specification | 9.613500e-3 |
GO:0000301 | retrograde transport, vesicle recycling within Golgi | 9.613500e-3 |
GO:0006119 | oxidative phosphorylation | 9.613500e-3 |
GO:0090084 | negative regulation of inclusion body assembly | 9.723077e-3 |
GO:0008334 | histone mRNA metabolic process | 1.001340e-2 |
GO:0043923 | positive regulation by host of viral transcription | 1.001340e-2 |
GO:0061136 | regulation of proteasomal protein catabolic process | 1.013444e-2 |
GO:0046671 | negative regulation of retinal cell programmed cell death | 1.031133e-2 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 1.031133e-2 |
GO:0006355 | regulation of transcription, DNA-dependent | 1.041191e-2 |
GO:0046755 | non-lytic virus budding | 1.049668e-2 |
GO:0071673 | positive regulation of smooth muscle cell chemotaxis | 1.049668e-2 |
GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 1.049668e-2 |
GO:0043393 | regulation of protein binding | 1.065642e-2 |
GO:0016570 | histone modification | 1.068843e-2 |
GO:0051574 | positive regulation of histone H3-K9 methylation | 1.077624e-2 |
GO:0042773 | ATP synthesis coupled electron transport | 1.080591e-2 |
GO:0006620 | posttranslational protein targeting to membrane | 1.080591e-2 |
GO:0021548 | pons development | 1.087627e-2 |
GO:0006099 | tricarboxylic acid cycle | 1.114157e-2 |
GO:0034067 | protein localization in Golgi apparatus | 1.142729e-2 |
GO:0021523 | somatic motor neuron differentiation | 1.142729e-2 |
GO:0010107 | potassium ion import | 1.149924e-2 |
GO:0055118 | negative regulation of cardiac muscle contraction | 1.151528e-2 |
GO:0051895 | negative regulation of focal adhesion assembly | 1.151528e-2 |
GO:0072148 | epithelial cell fate commitment | 1.179573e-2 |
GO:0035886 | vascular smooth muscle cell differentiation | 1.189903e-2 |
GO:0014040 | positive regulation of Schwann cell differentiation | 1.196201e-2 |
GO:0051461 | positive regulation of corticotropin secretion | 1.196201e-2 |
GO:0048936 | peripheral nervous system neuron axonogenesis | 1.196505e-2 |
GO:0045818 | negative regulation of glycogen catabolic process | 1.196505e-2 |
GO:0051036 | regulation of endosome size | 1.196505e-2 |
GO:0001987 | vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure | 1.196505e-2 |
GO:0032543 | mitochondrial translation | 1.196505e-2 |
GO:0015761 | mannose transport | 1.196505e-2 |
GO:0046627 | negative regulation of insulin receptor signaling pathway | 1.197497e-2 |
GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.198302e-2 |
GO:0042335 | cuticle development | 1.210190e-2 |
GO:0034470 | ncRNA processing | 1.233009e-2 |
GO:0006493 | protein O-linked glycosylation | 1.241493e-2 |
GO:0048704 | embryonic skeletal system morphogenesis | 1.242618e-2 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 1.251218e-2 |
GO:0072595 | maintenance of protein localization to organelle | 1.251558e-2 |
GO:0050434 | positive regulation of viral transcription | 1.278396e-2 |
GO:0031102 | neuron projection regeneration | 1.279914e-2 |
GO:0019400 | alditol metabolic process | 1.315746e-2 |
GO:0001709 | cell fate determination | 1.327178e-2 |
GO:0060674 | placenta blood vessel development | 1.327290e-2 |
GO:0010224 | response to UV-B | 1.328406e-2 |
GO:0032516 | positive regulation of phosphoprotein phosphatase activity | 1.335036e-2 |
GO:0034622 | cellular macromolecular complex assembly | 1.336514e-2 |
GO:0071895 | odontoblast differentiation | 1.340804e-2 |
GO:0016090 | prenol metabolic process | 1.340804e-2 |
GO:0043654 | recognition of apoptotic cell | 1.340804e-2 |
GO:0044265 | cellular macromolecule catabolic process | 1.348681e-2 |
GO:0007403 | glial cell fate determination | 1.349230e-2 |
GO:0046544 | development of secondary male sexual characteristics | 1.349230e-2 |
GO:0051013 | microtubule severing | 1.349230e-2 |
GO:0034214 | protein hexamerization | 1.349230e-2 |
GO:0072203 | cell proliferation involved in metanephros development | 1.353796e-2 |
GO:0009179 | purine ribonucleoside diphosphate metabolic process | 1.353796e-2 |
GO:0030825 | positive regulation of cGMP metabolic process | 1.353796e-2 |
GO:0010722 | regulation of ferrochelatase activity | 1.358823e-2 |
GO:0042699 | follicle-stimulating hormone signaling pathway | 1.360945e-2 |
GO:0021517 | ventral spinal cord development | 1.365052e-2 |
GO:0001578 | microtubule bundle formation | 1.409569e-2 |
GO:0046069 | cGMP catabolic process | 1.420393e-2 |
GO:0060045 | positive regulation of cardiac muscle cell proliferation | 1.431624e-2 |
GO:0043414 | macromolecule methylation | 1.432039e-2 |
GO:0048706 | embryonic skeletal system development | 1.444346e-2 |
GO:0021997 | neural plate axis specification | 1.448318e-2 |
GO:0010834 | telomere maintenance via telomere shortening | 1.448318e-2 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 1.458544e-2 |
GO:0055075 | potassium ion homeostasis | 1.461525e-2 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 1.461525e-2 |
GO:0016568 | chromatin modification | 1.469336e-2 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 1.469360e-2 |
GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity | 1.469360e-2 |
GO:0002524 | hypersensitivity | 1.488942e-2 |
GO:0032648 | regulation of interferon-beta production | 1.506134e-2 |
GO:0015812 | gamma-aminobutyric acid transport | 1.549866e-2 |
GO:0032859 | activation of Ral GTPase activity | 1.551419e-2 |
GO:0010468 | regulation of gene expression | 1.585030e-2 |
GO:2000779 | regulation of double-strand break repair | 1.593332e-2 |
GO:0015074 | DNA integration | 1.602763e-2 |
GO:0010556 | regulation of macromolecule biosynthetic process | 1.609490e-2 |
GO:0071480 | cellular response to gamma radiation | 1.613500e-2 |
GO:0071360 | cellular response to exogenous dsRNA | 1.613500e-2 |
GO:0030644 | cellular chloride ion homeostasis | 1.613500e-2 |
GO:0016540 | protein autoprocessing | 1.637391e-2 |
GO:0016569 | covalent chromatin modification | 1.644743e-2 |
GO:0006364 | rRNA processing | 1.649384e-2 |
GO:0032200 | telomere organization | 1.668710e-2 |
GO:0046006 | regulation of activated T cell proliferation | 1.676026e-2 |
GO:0031062 | positive regulation of histone methylation | 1.687989e-2 |
GO:0006612 | protein targeting to membrane | 1.699826e-2 |
GO:0070885 | negative regulation of calcineurin-NFAT signaling pathway | 1.708900e-2 |
GO:0010045 | response to nickel ion | 1.708900e-2 |
GO:0070625 | zymogen granule exocytosis | 1.708900e-2 |
GO:0035459 | cargo loading into vesicle | 1.708900e-2 |
GO:0016598 | protein arginylation | 1.708900e-2 |
GO:0032226 | positive regulation of synaptic transmission, dopaminergic | 1.720181e-2 |
GO:0006059 | hexitol metabolic process | 1.720181e-2 |
GO:2000286 | receptor internalization involved in canonical Wnt receptor signaling pathway | 1.733702e-2 |
GO:0060564 | negative regulation of mitotic anaphase-promoting complex activity | 1.733702e-2 |
GO:0006561 | proline biosynthetic process | 1.733702e-2 |
GO:0042552 | myelination | 1.737496e-2 |
GO:0032912 | negative regulation of transforming growth factor beta2 production | 1.760066e-2 |
GO:0035110 | leg morphogenesis | 1.767853e-2 |
GO:0008366 | axon ensheathment | 1.791331e-2 |
GO:2000623 | negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.817709e-2 |
GO:0019673 | GDP-mannose metabolic process | 1.817709e-2 |
GO:0018200 | peptidyl-glutamic acid modification | 1.820802e-2 |
GO:0048570 | notochord morphogenesis | 1.828006e-2 |
GO:0090083 | regulation of inclusion body assembly | 1.828006e-2 |
GO:0021545 | cranial nerve development | 1.833411e-2 |
GO:0021778 | oligodendrocyte cell fate specification | 1.835090e-2 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.837179e-2 |
GO:0035067 | negative regulation of histone acetylation | 1.863229e-2 |
GO:0021535 | cell migration in hindbrain | 1.869793e-2 |
GO:0048872 | homeostasis of number of cells | 1.885634e-2 |
GO:0001937 | negative regulation of endothelial cell proliferation | 1.904191e-2 |
GO:0070647 | protein modification by small protein conjugation or removal | 1.915683e-2 |
GO:0070972 | protein localization in endoplasmic reticulum | 1.974790e-2 |
GO:0006353 | transcription termination, DNA-dependent | 1.987688e-2 |
GO:0071635 | negative regulation of transforming growth factor beta production | 1.991487e-2 |
GO:0035116 | embryonic hindlimb morphogenesis | 2.017665e-2 |
GO:0045943 | positive regulation of transcription from RNA polymerase I promoter | 2.033977e-2 |
GO:0070166 | enamel mineralization | 2.053935e-2 |
GO:0006312 | mitotic recombination | 2.053935e-2 |
GO:0070925 | organelle assembly | 2.062974e-2 |
GO:0055021 | regulation of cardiac muscle tissue growth | 2.082271e-2 |
GO:0060043 | regulation of cardiac muscle cell proliferation | 2.087725e-2 |
GO:0021796 | cerebral cortex regionalization | 2.089114e-2 |
GO:0000387 | spliceosomal snRNP assembly | 2.089114e-2 |